A Real life Impact Of Switching TAF-based cART or Dual Combinations (DC) From TDF-based Regimens In Patients With HIV-Infections
Latest Information Update: 03 Sep 2021
At a glance
- Drugs Cabotegravir+rilpivirine (Primary) ; Cobicistat/elvitegravir (Primary) ; Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide (Primary) ; Dolutegravir/rilpivirine (Primary)
- Indications HIV infections
- Focus Therapeutic Use
Most Recent Events
- 21 Jul 2021 Results presented at the 11th International AIDS Society Conference on HIV Science
- 30 Jan 2020 New trial record